Patent · US Active

4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

US9550754B2 · kind B2 · utility

0Cited by

8References

20Claims

0Family size

Assignees

Abb Vie Deutschland Gmbh & Co. KG · DE
Abb Vie Inc. · US

Inventors

Wilhelm Amberg · Ludwigshafen, DE
Jason T. Brewer · Zion, US
Charles W. Hutchins · Libertyville, US
Udo Lange · Ludwigshafen, DE
Yanbin Lao · Libertyville, US
Huan-Qiu Li · Cambridge, US
Frauke Pohlki · Wiesbaden, DE
Anil Vasudevan · Union Grove, US
Ying Wang · Lake Villa, US
Hongyu Zhao · Libertyville, US

Key dates

Filing date	Sep 9, 2015
Grant date	Jan 24, 2017
Priority date	—
Expiry date	Sep 9, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to 4,5-dihydropyrazole derivatives of the formula (I)and physiologically tolerated salts thereof which are GlyT1 inhibitors. The invention further relates to pharmaceutical compositions comprising such 4,5-dihydropyrazole derivatives, and the use of such 4,5-dihydropyrazole derivatives for therapeutic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.